The biopharmaceutical industry is at the forefront of COVID-19 news due to major advances in vaccine development. Now, more than a year since the first case of COVID-19 and nearing a year since daily life has been upended by...more
12/1/2020
/ AstraZeneca ,
Coronavirus/COVID-19 ,
Emergency Use Authorization (EUA) ,
Infectious Diseases ,
Intellectual Property Protection ,
Life Sciences ,
Moderna Inc. ,
Pfizer ,
Public Health ,
Research and Development ,
Vaccinations